A Epidemiologist in India earns from around ₹5.0 LPA at entry level, reaching up to ₹55.0 LPA at senior level (2026). Market demand is strong. Full guide to earning potential, growth path and the skills that move the number.
| City | Typical pay | What drives it |
|---|---|---|
| ICMR Institutes — NIE Chennai, NIRT Chennai, NIN Hyderabad, NCMH Delhi | ₹5L (JRF) – ₹55L (Scientist-E) | Permanent govt posts on ICMR pay scales (Level 7–14). Scientist-B entry: basic ₹56,100 (Level 10) + allowances ≈ ₹10–14L total. Scientist-E senior: ₹1,44,200 basic + allowances ≈ ₹28–45L. Research Associates / Project Scientists on funded grants: ₹5–8L — common entry for fresh MPH graduates. |
| NCDC Delhi / State IDSP Cells | ₹5L – ₹25L | NCDC Scientist posts on central govt scales similar to ICMR. State IDSP cells hire State Epidemiologists and District Surveillance Officers via NHM State Health Society contracts at ₹35–70K/month (₹4.2–8.4L/yr). FETP fellows at stipend ₹55–80K/month. |
| WHO India, CDC India, UNICEF (New Delhi hub) | ₹10L – ₹90L | WHO India NPO (NO-B/NO-C level): ₹12–25L. WHO Technical Officer / Senior NPO: ₹28–50L. CDC India Field Epidemiologist: ₹15–30L. UNICEF Health Specialist: ₹18–35L. Senior WHO Technical Officer / P-4 equivalent: ₹40–90L. Fixed-term contracts; benefits include health insurance and UN pension contribution. |
| PHFI / Academic Research Institutions (Delhi, Hyderabad, Bhubaneswar) |
|---|
| ₹7L – ₹35L |
| PHFI Senior Research Scientist: ₹14–28L. Assistant Professor with epidemiology focus at IIPH / PHFI: ₹14–22L. AIIMS Department of Epidemiology faculty: ₹14–38L (7th CPC academic pay matrix). IIPS Mumbai: ₹12–35L for faculty. |
| NGOs — PATH, JHPIEGO, CHAI, MSF, CARE India (field + Delhi) | ₹7L – ₹45L | Entry Research Associate / Epidemiology Advisor: ₹7–12L. Senior programme epidemiologist / M&E lead: ₹18–35L. Country Epidemiology Lead or Health Security Director: ₹40–65L. MSF Epidemiologist (field posting): ₹3.5–5L/month (₹42–60L/yr) including field hardship allowance. |
|---|
| Pharma / CRO (Real-World Evidence / Pharmacoepidemiology) | ₹10L – ₹50L | Real-world evidence and pharmacoepidemiology roles at IQVIA India, ICON, Parexel, and Indian pharma majors (Cipla, Sun, Dr. Reddy's): MPH/PhD epidemiologist ₹10–20L entry; senior ₹25–50L. Growing segment post-2023 as CDSCO and pharma companies increasingly require Phase IV real-world safety and effectiveness studies. |
|---|